D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 54 Citations 16,857 130 World Ranking 10837 National Ranking 311

Overview

What is she best known for?

The fields of study she is best known for:

  • Internal medicine
  • Cancer
  • Immune system

Her primary scientific interests are in Mesenchymal stem cell, Cell biology, Stem cell, Microvesicles and Pathology. Stefania Bruno interconnects Cell and Paracrine signalling in the investigation of issues within Mesenchymal stem cell. Her Cell biology study often links to related topics such as Immunology.

In her research on the topic of Stem cell, Stem cell marker is strongly related with Adult stem cell. Her work on Microvesicle and Exosome as part of general Microvesicles research is frequently linked to Angiogenesis, Reprogramming and Cell growth, thereby connecting diverse disciplines of science. Her studies deal with areas such as Apoptosis, Cancer research, Kidney and CD44 as well as Pathology.

Her most cited work include:

  • Mesenchymal Stem Cell-Derived Microvesicles Protect Against Acute Tubular Injury (882 citations)
  • Exosomes/microvesicles as a mechanism of cell-to-cell communication (797 citations)
  • Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. (750 citations)

What are the main themes of her work throughout her whole career to date?

Her primary areas of study are Stem cell, Cell biology, Mesenchymal stem cell, Microvesicles and Pathology. Her study in Stem cell is interdisciplinary in nature, drawing from both Molecular biology, Immunology, Cord blood and Adult stem cell. While the research belongs to areas of Cell biology, Stefania Bruno spends her time largely on the problem of Angiogenesis, intersecting her research to questions surrounding Cell cycle.

Stefania Bruno usually deals with Mesenchymal stem cell and limits it to topics linked to Stem cell transplantation for articular cartilage repair and Clinical uses of mesenchymal stem cells. In general Microvesicles study, her work on Exosome and Microvesicle often relates to the realm of Cancer research, Regenerative medicine and Reprogramming, thereby connecting several areas of interest. She has researched Pathology in several fields, including Acute kidney injury, Flow cytometry and Amniotic epithelial cells.

She most often published in these fields:

  • Stem cell (49.24%)
  • Cell biology (40.91%)
  • Mesenchymal stem cell (37.88%)

What were the highlights of her more recent work (between 2018-2021)?

  • Cell biology (40.91%)
  • Stem cell (49.24%)
  • Mesenchymal stem cell (37.88%)

In recent papers she was focusing on the following fields of study:

Her main research concerns Cell biology, Stem cell, Mesenchymal stem cell, Inflammation and Microvesicles. Her work carried out in the field of Cell biology brings together such families of science as Cell, In vitro and Nucleic acid. Her studies deal with areas such as Cancer research, Liver transplantation, Paracrine signalling and Liver regeneration as well as Stem cell.

Her Mesenchymal stem cell study combines topics from a wide range of disciplines, such as Stromal cell, Extracellular vesicles, Cell therapy and Regeneration. Her Inflammation study incorporates themes from Fibrosis, Liver function, Pharmacology and Pathogenesis. Stefania Bruno does research in Microvesicles, focusing on Exosome specifically.

Between 2018 and 2021, her most popular works were:

  • Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. (360 citations)
  • Defining mesenchymal stromal cell (MSC)-derived small extracellular vesicles for therapeutic applications (121 citations)
  • Mesenchymal Stromal Cell Derived Extracellular Vesicles Reduce Hypoxia-Ischaemia Induced Perinatal Brain Injury. (24 citations)

In her most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Immune system

Her primary areas of investigation include Stem cell, Mesenchymal stem cell, Cell biology, In vitro and Microvesicles. Stefania Bruno interconnects Liver function, Cell type and Cancer research in the investigation of issues within Stem cell. Her work carried out in the field of Mesenchymal stem cell brings together such families of science as Stromal cell and Extracellular vesicles.

Her biological study spans a wide range of topics, including Microglia, Computational biology, Neuroprotection and Ischemia. Stefania Bruno combines subjects such as Cellular origin, Kidney, Transfection and Regeneration with her study of In vitro. Paracrine Communication, Nucleic acid, Cancer cell, Extracellular and Signal transduction are fields of study that overlap with her Microvesicles research.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Mesenchymal Stem Cell-Derived Microvesicles Protect Against Acute Tubular Injury

Stefania Bruno;Cristina Grange;Maria Chiara Deregibus;Raffaele A. Calogero.
Journal of The American Society of Nephrology (2009)

1202 Citations

Exosomes/microvesicles as a mechanism of cell-to-cell communication

Giovanni Camussi;Maria C Deregibus;Stefania Bruno;Vincenzo Cantaluppi.
Kidney International (2010)

1196 Citations

Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA.

Maria Chiara Deregibus;Vincenzo Cantaluppi;Raffaele Calogero;Marco Lo Iacono.
Blood (2007)

1039 Citations

Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study.

Aravinthan Varatharaj;Aravinthan Varatharaj;Naomi Thomas;Mark A Ellul;Mark A Ellul;Mark A Ellul;Nicholas W S Davies.
The Lancet Psychiatry (2020)

990 Citations

Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury

Stefano Gatti;Stefania Bruno;Maria Chiara Deregibus;Andrea Sordi.
Nephrology Dialysis Transplantation (2011)

855 Citations

Isolation of Renal Progenitor Cells from Adult Human Kidney

Benedetta Bussolati;Stefania Bruno;Cristina Grange;Stefano Buttiglieri.
American Journal of Pathology (2005)

753 Citations

Microvesicles Derived from Adult Human Bone Marrow and Tissue Specific Mesenchymal Stem Cells Shuttle Selected Pattern of miRNAs

Federica Collino;Maria Chiara Deregibus;Stefania Bruno;Luca Sterpone.
PLOS ONE (2010)

684 Citations

Microvesicles Derived from Mesenchymal Stem Cells Enhance Survival in a Lethal Model of Acute Kidney Injury

Stefania Bruno;Cristina Grange;Federica Collino;Maria Chiara Deregibus.
PLOS ONE (2012)

612 Citations

Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury

Maria Beatriz Herrera;Benedetta Bussolati;Stefania Bruno;Valentina Fonsato.
International Journal of Molecular Medicine (2004)

579 Citations

Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia–reperfusion injury by microRNA-dependent reprogramming of resident renal cells

Vincenzo Cantaluppi;Stefano Gatti;Davide Medica;Federico Figliolini.
Kidney International (2012)

549 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Stefania Bruno

Giovanni Camussi

Giovanni Camussi

University of Turin

Publications: 129

Benedetta Bussolati

Benedetta Bussolati

University of Turin

Publications: 77

Maria Chiara Deregibus

Maria Chiara Deregibus

University of Turin

Publications: 38

Peter J. Quesenberry

Peter J. Quesenberry

Brown University

Publications: 37

Sai Kiang Lim

Sai Kiang Lim

Agency for Science, Technology and Research

Publications: 37

Giuseppe Remuzzi

Giuseppe Remuzzi

Mario Negri Institute for Pharmacological Research

Publications: 28

Mariusz Z. Ratajczak

Mariusz Z. Ratajczak

University of Louisville

Publications: 28

Bernd Giebel

Bernd Giebel

University of Duisburg-Essen

Publications: 25

Masoud Soleimani

Masoud Soleimani

Tarbiat Modares University

Publications: 24

Hui Qian

Hui Qian

Jiangsu University

Publications: 24

Wenrong Xu

Wenrong Xu

Jiangsu University

Publications: 23

Anthony Atala

Anthony Atala

Wake Forest University

Publications: 22

Michael Chopp

Michael Chopp

Oakland University

Publications: 22

Michael A. Matthay

Michael A. Matthay

University of California, San Francisco

Publications: 21

Paola Romagnani

Paola Romagnani

University of Florence

Publications: 21

Juan M. Falcon-Perez

Juan M. Falcon-Perez

Ikerbasque

Publications: 20

Trending Scientists

Darko Marinov

Darko Marinov

University of Illinois at Urbana-Champaign

Gary T. Leavens

Gary T. Leavens

University of Central Florida

Larry E. Jones

Larry E. Jones

University of Minnesota

Brian F. Roberts

Brian F. Roberts

Verizon (United States)

Dean M. DeLongchamp

Dean M. DeLongchamp

National Institute of Standards and Technology

Matthew L. Forister

Matthew L. Forister

University of Nevada, Reno

Toshiyuki Fukada

Toshiyuki Fukada

RIKEN Center for Integrative Medical Sciences

Kwen-Tay Luh

Kwen-Tay Luh

National Taiwan University

Karl Grönvold

Karl Grönvold

University of Iceland

Ying Wang

Ying Wang

Beijing Normal University

Barnett S. Kramer

Barnett S. Kramer

National Institutes of Health

Göran Pershagen

Göran Pershagen

Karolinska Institute

John Fien

John Fien

RMIT University

Antonaldo Diaferio

Antonaldo Diaferio

University of Turin

Nigel Metcalfe

Nigel Metcalfe

Durham University

Cedric G. Lacey

Cedric G. Lacey

Durham University

Something went wrong. Please try again later.